Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Nutrition (Burbank, Los Angeles County, Calif.)|March 15, 2019
Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver diseaseBianca M Arendt, Anastasia Teterina, Paulina Pettinelli, et al.Liver International : Official Journal of the International Association for the Study of the Liver|February 14, 2024
Links between gut microbiome, metabolome, clinical variables and non-alcoholic fatty liver disease severity in bariatric patientsKatherine J P Schwenger, Divya Sharma, Yasaman Ghorbani, et al.Plos One|May 21, 2016
Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver DiseaseMarialena Mouzaki, Alice Y Wang, Robert Bandsma, et al.Microbiome|January 14, 2025
Characterization of liver, adipose, and fecal microbiome in obese patients with MASLD: links with disease severity and metabolic dysfunction parametersKatherine J P Schwenger, Julia K Copeland, Yasaman Ghorbani, et al.The Science of the Total Environment|September 11, 2024
Links between fecal microplastics and parameters related to metabolic dysfunction-associated steatotic liver disease (MASLD) in humans: An exploratory studyKatherine J P Schwenger, Yasaman Ghorbani, Sharvika Bharatselvam, et al.Hepatology (Baltimore, Md.)|January 13, 2015
Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acidsBianca M Arendt, Elena M Comelli, David W L Ma, et al.Obesity Surgery|June 28, 2023
Adipose Tissue and Plasma Markers Associated with HbA1c Pre- and Post-bariatric Surgery: a Cross-sectional and Cohort StudySara H Keshavjee, Katherine J P Schwenger, Jitender Yadav, et al.The Journal of Pathology|September 28, 2023
Hourglass, a rapid analysis framework for heterogeneous bioimaging data, identifies sex disparity in IL-6/STAT3-associated immune phenotypes in pancreatic cancerKazeera Aliar, Henry R Waterhouse, Foram Vyas, et al.Journal of Clinical Pathology|September 29, 2021
Molecular characterisation of pancreatic ductal adenocarcinoma with NTRK fusions and review of the literatureMichael J Allen, Amy Zhang, Prashant Bavi, et al.Journal of Gastrointestinal Oncology|January 13, 2023
A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinomaKyaw L Aung, Elaine McWhirter, Stephen Welch, et al.Pageof 5